CCCC
Price
$4.34
Change
+$0.08 (+1.88%)
Updated
Jun 29, 04:59 PM (EDT)
Capitalization
471.02M
44 days until earnings call
Intraday BUY SELL Signals
PMVP
Price
$1.27
Change
+$0.08 (+6.72%)
Updated
Jun 29, 04:59 PM (EDT)
Capitalization
63.46M
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs PMVP

CCCC vs PMVP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CCCC vs. PMVP commentary
Jun 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Buy and PMVP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2026
Stock price -- (CCCC: $4.26 vs. PMVP: $1.19)
Brand notoriety: CCCC and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 666% vs. PMVP: 52%
Market capitalization -- CCCC: $471.02M vs. PMVP: $63.46M
CCCC [@Biotechnology] is valued at $471.02M. PMVP’s [@Biotechnology] market capitalization is $63.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whilePMVP’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 4 bearish.
  • PMVP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than PMVP.

Price Growth

CCCC (@Biotechnology) experienced а +2.65% price change this week, while PMVP (@Biotechnology) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.51%. For the same industry, the average monthly price growth was +2.14%, and the average quarterly price growth was +1975.65%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 12, 2026.

PMVP is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+4.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($471M) has a higher market cap than PMVP($63.5M). CCCC YTD gains are higher at: 123.037 vs. PMVP (-4.800). PMVP has higher annual earnings (EBITDA): -83.53M vs. CCCC (-101.2M). CCCC has more cash in the bank: 236M vs. PMVP (93.5M). PMVP has less debt than CCCC: PMVP (293K) vs CCCC (58.4M). CCCC has higher revenues than PMVP: CCCC (34.9M) vs PMVP (0).
CCCCPMVPCCCC / PMVP
Capitalization471M63.5M742%
EBITDA-101.2M-83.53M121%
Gain YTD123.037-4.800-2,563%
P/E RatioN/AN/A-
Revenue34.9M0-
Total Cash236M93.5M252%
Total Debt58.4M293K19,932%
TECHNICAL ANALYSIS
Technical Analysis
CCCCPMVP
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSRNX18.210.27
+1.51%
Fidelity Real Estate Index
JGRTX142.30N/A
N/A
Janus Henderson Enterprise S
JAWGX78.94N/A
N/A
Janus Henderson VIT Global Rsrch Instl
RAIRX30.39-0.06
-0.20%
Manning & Napier Rainier Intl Discv Z
JOMMX16.54-0.37
-2.19%
JOHCM Emerging Mkts Discovery Instl